Acelyrin, Inc.
SLRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $238 | $229 | $231 | $38 |
| G&A Expenses | $67 | $66 | $24 | $4 |
| SG&A Expenses | $67 | $64 | $24 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $304 | $293 | $255 | $42 |
| Operating Income | -$316 | -$422 | -$69 | -$42 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $68 | $40 | $4 | -$0 |
| Pre-Tax Income | -$248 | -$382 | -$65 | -$42 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$248 | -$382 | -$250 | -$42 |
| % Margin | – | – | – | – |
| EPS | -2.5 | -5.43 | -0.7 | -2.05 |
| % Growth | 54% | -675.7% | 65.9% | – |
| EPS Diluted | -2.5 | -5.43 | -0.7 | -2.05 |
| Weighted Avg Shares Out | 99 | 70 | 20 | 20 |
| Weighted Avg Shares Out Dil | 99 | 70 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $31 | $31 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$248 | -$382 | -$65 | -$42 |
| % Margin | – | – | – | – |